Literature DB >> 25599283

Commentary: The place of tenofovir disoproxil fumarate in pediatric antiretroviral therapy.

Peter L Havens1, Rohan Hazra.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25599283      PMCID： PMC4357556          DOI： 10.1097/INF.0000000000000650

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN： 0891-3668            Impact factor:   2.129


× No keyword cloud information.
  16 in total

1.  Tenofovir disoproxil fumarate and an optimized background regimen of antiretroviral agents as salvage therapy for pediatric HIV infection.

Authors:  Rohan Hazra; Rachel I Gafni; Frank Maldarelli; Frank M Balis; Antonella N Tullio; Ellen DeCarlo; Carol J Worrell; Seth M Steinberg; John Flaherty; Kitty Yale; Brian P Kearney; Steven L Zeichner
Journal:  Pediatrics       Date:  2005-11-15       Impact factor: 7.124

2.  Tenofovir DF, emtricitabine, and efavirenz vs. zidovudine, lamivudine, and efavirenz for HIV.

Authors:  Joel E Gallant; Edwin DeJesus; José R Arribas; Anton L Pozniak; Brian Gazzard; Rafael E Campo; Biao Lu; Damian McColl; Steven Chuck; Jeffrey Enejosa; John J Toole; Andrew K Cheng
Journal:  N Engl J Med       Date:  2006-01-19       Impact factor: 91.245

3.  Long-term efficacy and safety of tenofovir disoproxil fumarate in HIV-1-infected adolescents failing antiretroviral therapy: the final results of study GS-US-104-0321.

Authors:  Marinella Della Negra; Aroldo Prohmann De Carvalho; Maria Zilda De Aquino; Jorge Andrade Pinto; Marcos Tadeu Nolasco Da Silva; Kristen N Andreatta; Bryan Graham; Ya-Pei Liu; Erin K Quirk
Journal:  Pediatr Infect Dis J       Date:  2015-04       Impact factor: 2.129

4.  Efficacy, safety and pharmacokinetics of tenofovir disoproxil fumarate in virologic-suppressed HIV-infected children using weight-band dosing.

Authors:  Linda Aurpibul; Tim R Cressey; Sirintip Sricharoenchai; Orasri Wittawatmongkol; Virat Sirisanthana; Wanatpreeya Phongsamart; Tavitiya Sudjaritruk; Kulkanya Chokephaibulkit
Journal:  Pediatr Infect Dis J       Date:  2015-04       Impact factor: 2.129

5.  A randomized, open-label study of the safety and efficacy of switching stavudine or zidovudine to tenofovir disoproxil fumarate in HIV-1-infected children with virologic suppression.

Authors:  Xavier Saez-Llorens; Elizabeth Castaño; Mobeen Rathore; Joseph Church; Jaime Deville; Aditya Gaur; Dora Estripeaut; Kirsten White; Sarah Arterburn; Jeffrey V Enejosa; Andrew K Cheng; Steven L Chuck; Martin S Rhee
Journal:  Pediatr Infect Dis J       Date:  2015-04       Impact factor: 2.129

6.  Tenofovir treatment duration predicts proteinuria in a multiethnic United States Cohort of children and adolescents with perinatal HIV-1 infection.

Authors:  Murli Purswani; Kunjal Patel; Jeffrey B Kopp; George R Seage; Miriam C Chernoff; Rohan Hazra; George K Siberry; Lynne M Mofenson; Gwendolyn B Scott; Russell B Van Dyke
Journal:  Pediatr Infect Dis J       Date:  2013-05       Impact factor: 2.129

7.  Tenofovir alafenamide vs. tenofovir disoproxil fumarate in single tablet regimens for initial HIV-1 therapy: a randomized phase 2 study.

Authors:  Paul E Sax; Andrew Zolopa; Indira Brar; Richard Elion; Roberto Ortiz; Frank Post; Hui Wang; Christian Callebaut; Hal Martin; Marshall W Fordyce; Scott McCallister
Journal:  J Acquir Immune Defic Syndr       Date:  2014-09-01       Impact factor: 3.731

Review 8.  Review of tenofovir use in HIV-infected children.

Authors:  Linda Aurpibul; Thanyawee Puthanakit
Journal:  Pediatr Infect Dis J       Date:  2015-04       Impact factor: 2.129

9.  Single-dose and steady-state pharmacokinetics of tenofovir disoproxil fumarate in human immunodeficiency virus-infected children.

Authors:  Rohan Hazra; Frank M Balis; Antonella N Tullio; Ellen DeCarlo; Carol J Worrell; Seth M Steinberg; John F Flaherty; Kitty Yale; Marianne Poblenz; Brian P Kearney; Lijie Zhong; Dion F Coakley; Stephane Blanche; Jean Louis Bresson; Judith A Zuckerman; Steven L Zeichner
Journal:  Antimicrob Agents Chemother       Date:  2004-01       Impact factor: 5.191

10.  Antiretroviral treatment of adult HIV infection: 2014 recommendations of the International Antiviral Society-USA Panel.

Authors:  Huldrych F Günthard; Judith A Aberg; Joseph J Eron; Jennifer F Hoy; Amalio Telenti; Constance A Benson; David M Burger; Pedro Cahn; Joel E Gallant; Marshall J Glesby; Peter Reiss; Michael S Saag; David L Thomas; Donna M Jacobsen; Paul A Volberding
Journal:  JAMA       Date:  2014 Jul 23-30       Impact factor: 157.335
View more
  3 in total

1.  Paediatric HIV: Progress on Prevention, Treatment and Cure.

Authors:  Maria H Kim; Saeed Ahmed; Elaine J Abrams
Journal:  Curr Pediatr Rep       Date:  2015-07-22

2.  Viral load care of HIV-1 infected children and adolescents: A longitudinal study in rural Zimbabwe.

Authors:  Tichaona Mapangisana; Rhoderick Machekano; Vinie Kouamou; Caroline Maposhere; Kathy McCarty; Marceline Mudzana; Shungu Munyati; Junior Mutsvangwa; Justen Manasa; Tinei Shamu; Mampedi Bogoshi; Dennis Israelski; David Katzenstein
Journal:  PLoS One       Date:  2021-01-14       Impact factor: 3.240

3.  Safety and efficacy of abacavir for treating infants, children, and adolescents living with HIV: a systematic review and meta-analysis.

Authors:  Julie Jesson; Laura Saint-Lary; Marc Harris Dassi Tchoupa Revegue; John O'Rourke; Claire L Townsend; Françoise Renaud; Martina Penazzato; Valériane Leroy
Journal:  Lancet Child Adolesc Health       Date:  2022-09-02
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.